Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

BATM Advanced Communications (BAV) AI Stock Analysis

DE:BAV

BATM Advanced Communications

(Frankfurt:BAV)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Accelerating Revenue GrowthRevenue returned to growth and accelerated in 2025, indicating improving demand across the company’s communications and cybersecurity activities. If maintained, this top-line recovery can provide greater operating scale and create a foundation for restoring profitability over the next several quarters.
Negative Factors
Persistent Net LossesThe company remains materially loss-making despite the year-on-year improvement, showing that revenue growth has not yet translated into dependable earnings. Persistent losses reduce internal funding capacity, make results more sensitive to execution, and leave the turnaround dependent on sustained operating improvement.

BATM Advanced Communications (BAV) vs. iShares MSCI Germany ETF (EWG)

-40%-30%-20%-10%0%10%20%30%DE:BAV-26.86%EWG+4.43%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
EUR 38.34M
Dividend Yield
―
Average Volume (3M)
3,915
Price to Earnings (P/E)
-3.8
Beta (1Y)
0.27
Revenue Growth
0.62%
EPS Growth
36.65%
Country
Germany
Employees
867
Sector
Healthcare
Sector Strength
51
Industry
Medical - Instruments & Supplies

BATM Advanced Communications Business Overview & Revenue Model

Company Description

BATM Advanced Communications Ltd., together with its various group companies, delivers cutting-edge real-time technologies for both sophisticated networking solutions and advanced biomedical systems. The company operates across Israel, the United Sta...

BATM Advanced Communications Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

DE:BAV against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
GB:EKFGB:EKF64NeutralGBP 102.71M41.383.58%―2.26%-57.04%
GB:DXRXGB:DXRX59NeutralGBP 172.63M-635.94-0.68%―20.14%82.22%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
GB:ABDXGB:ABDX46NeutralGBP 22.75M-16.36-34.31%―30.42%43.16%
GB:RENXGB:RENX44NeutralGBP 36.54M-3.44675.00%―――
GB:CNSLGB:CNSL43NeutralGBP 3.69M-0.63-69.62%―-16.27%-471.21%

* Healthcare Sector Average

Performance Comparison

-50%0%50%100%DE:BAVGB:EKFGB:CNSLGB:RENXGB:DXRXGB:ABDXDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
DE:BAV and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:BAVBATM Advanced Communications Ltd.0.13-0.05-29.28%
GB:EKFEKF Diagnostics Holdings24.00-2.20-8.40%
GB:CNSLOmega Diagnostics1.55-1.10-41.51%
GB:RENXRenalytix Plc OTC5.45-1.93-26.15%
GB:DXRXDiaceutics Plc203.5041.0025.23%
GB:ABDXAbingdon Health PLC9.002.7544.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.